Delivery Order SPE2DB24D3013-SPE2DB25FFKQL
Award Date
4/2/25
Potential Completion Date
4/3/25
Potential Value
$1.9K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award, identified as SPE2DB25D3109|SPE2DB25FPJZR, was issued by the Defense Logistics Agency (DLA) to the prime contractor Amerisourcebergen Drug Corp. The contract has a total ceiling value of $2,711.94 and is for the delivery of 4567423108 ! VYVANSE 50 MG CAPSULE 100S. The contract is a Firm Fixed Price Delivery Order with an ultimate completion date of March 3, 2025. Amerisourcebergen Drug Corp is a major pharmaceutical distributor and healthcare solutions provider...
This federal contract award, with an ID of SPE2DB22D3010|SPE2DB25FP2AN, was issued by the Defense Logistics Agency (DLA) to the prime contractor Amerisourcebergen Drug Corp. The contract is for the delivery of 4567717274 ! VYVANSE 20 MG CAPSULE 100S, a pharmaceutical product, with a ceiling value of $1,269.56. The contract type is a Delivery Order with a Firm Fixed Price pricing type. The period of performance runs through March 28, 2025. The contract is not designated as a set-aside....
This federal contract award, with ID SPE2DB24D1104|SPE2DB25FXZV5, was issued by the Defense Logistics Agency (DLA) to the prime contractor Amerisourcebergen Drug Corp. The $1,192.05 Firm Fixed Price delivery order is for the supply of 4567903376 VYVANSE 50 MG CAPSULE 100S. This award is part of a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026. The IDC serves as a primary vehicle for Amerisourcebergen to...
This federal contract award, with ID SPE2DB22D3004|SPE2DB25FNJ00, was issued by the Defense Logistics Agency (DLA) to the prime contractor Amerisourcebergen Drug Corp. The $5,978.80 Firm Fixed Price Delivery Order contract is for the supply of 4566265008 - VYVANSE 10 MG CAPSULE 100S. This contract does not have a set-aside designation, indicating open competition. Amerisourcebergen Drug Corp is a major pharmaceutical distributor and healthcare solutions provider that plays a critical role in...
This federal contract award, identified as SPE2DB24D1034|SPE2DB25FWAN1, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of 4567291398 VYVANSE 50 MG CAPSULE 100S, a prescription medication, with a ceiling value of $1,155.86. The contract is a Delivery Order with a Firm Fixed Price pricing type, and has an ultimate completion date of February 18, 2025. The...
This federal contract award, identified as SPE2DB20D3505|SPE2DB25FU1Y8, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of 4567604164 VYVANSE 60 MG CAPSULE 100S, a prescription medication, with a ceiling value of $1,337.70 and a performance period through March 18, 2025. The contract is a Delivery Order under a larger Indefinite Delivery Contract (IDC) valued at...
This federal contract award with ID SPE2DB22D2007|SPE2DB24FJ6CP was issued by the Defense Logistics Agency (DLA) to the prime contractor Amerisourcebergen Drug Corp for the delivery of 4565802104 VYVANSE 50 MG CAPSULE 100S. The firm fixed price delivery order has a ceiling value of $19,360.50 and an ultimate completion date of September 16, 2024. This contract is not set aside for any specific business type. Amerisourcebergen Drug Corp, a major pharmaceutical distributor, will be responsible for...
This federal contract award, with an ID of SPE2DB22D1106|SPE2DB25FDSD8, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of VYVANSE 50 MG CAPSULE 100S, a pharmaceutical product, with a ceiling value of $12,376.39 and a completion date of December 30, 2024. The contract is a Delivery Order with a Firm Fixed Price pricing type, and it is not designated as a...
This federal contract award, with ID SPE2DB20D1051|SPE2DB25FD5YH, was issued by the Defense Logistics Agency (DLA) to the prime contractor Amerisourcebergen Drug Corp. The contract is for the delivery of 4566188939 VYVANSE 30 MG CAPSULE 100S, with a ceiling value of $2,196.04. The contract is a Delivery Order with a Firm Fixed Price pricing type, and has an ultimate completion date of October 24, 2024. The contract was awarded on October 23, 2024 and does not have a set-aside designation....
This federal contract award, with ID SPE2DB22D1002|SPE2DB25FKYA8, was issued by the Defense Logistics Agency (DLA) to the prime contractor Amerisourcebergen Drug Corp. The contract, which is a Delivery Order with a Firm Fixed Price pricing type, is for the supply of 4567237364 - VYVANSE 30 MG CAPSULE 100S. The contract has a ceiling value of $1,120.49 and an ultimate completion date of February 12, 2025. Amerisourcebergen Drug Corp is a major pharmaceutical distributor and healthcare solutions...